Therapeutics News

ORLANDO, Fla. – Eyevance Pharmaceuticals has completed seven transactions over the last 2 years that have resulted in the company bringing 10 products to the market, Jerry St. Peter, CEO and co-founder, said.

ORLANDO, Fla. – Jacob Lang, OD, FAAO; Mark Buboltz, OD, FAAO; Jaclyn Garlich, OD, FAAO; and Roya Habibi, OD, FAAO, FSLS, shared some of the highlights of their fast-paced “Optometric Year in Review” course here at the American Academy of Optometry meeting.

ORLANDO, Fla. – A single in-office dose of 5% povidone-iodine in patients who tested positive for adenoviral conjunctivitis resulted in an improvement in signs and symptoms and a decrease in viral titers.

Sun Pharmaceutical Industries announced the U.S. launch of Cequa, a topical ophthalmic treatment indicated to increase tear production in patients with keratoconjunctivitis sicca.

EyeMedsNow is a new comprehensive database with pharmaceutical information targeted to eye doctors.

The combination of netarsudil and latanoprost proved to be superior in treating glaucoma compared with the use of the two drugs by themselves, according to findings published in the American Journal of Ophthalmology.

Gonioscopy-assisted transluminal trabeculotomy effectively decreases IOP and medication burden in patients with steroid-induced glaucoma, a recent study suggests.

High serum cholesterol levels are associated with increased risk for primary open-angle glaucoma, while 5 or more years of statin use decrease the risk, a recent study suggests.

Preliminary study results show significant improvement in dry eye questionnaire scores, subjective symptoms and corneal staining in patients with using 0.1% cyclosporine in chondroitin sulfate ophthalmic emulsion.

VANCOUVER, British Columbia – Results from phase 2 and phase 3 trials showed that tivanisiran 1.125% significantly improved ocular discomfort/pain and conjunctival hyperemia in patients with dry eye and also confirmed its safety profile.